Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer
Authors:
- 29 May 2018
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. Preprint (Preprint) , 1-7
Abstract
BACKGROUND: Colorectal cancer (CRC) is one of the common cancer types and the leading cause of cancer related death around the world. Identification of reliable biomarkers contributes to facilitate disease detection of this malignancy. OBJECTIVE: ThiKeywords
This publication has 24 references indexed in Scilit:
- Recent advances in personalized colorectal cancer researchCancer Letters, 2014
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal CancerAnnals of Surgery, 2014
- Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal CancerJNCI: Journal of the National Cancer Institute, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Therapeutic strategy in unresectable metastatic colorectal cancerTherapeutic Advances in Medical Oncology, 2011
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- MicroRNAs and Glial Cell DevelopmentThe Neuroscientist, 2011
- CT Colonography Versus Optical Colonoscopy for Screening Asymptomatic Patients for Colorectal Cancer: A Patient, Intervention, Comparison, Outcome (PICO) AnalysisAcademic Radiology, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- MicroRNA expression profiles classify human cancersNature, 2005